• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞移动抑制因子(MIF)基因-173 G/C多态性与炎症性肠病风险:一项荟萃分析

The -173 G/C polymorphism of the MIF gene and inflammatory bowel disease risk: a meta-analysis.

作者信息

Shen Yongchun, Guo Shujin, Yang Ting, Jia Liuqun, Chen Lei, An Jing, Wang Tao, Wen Fuqiang

机构信息

Division of Internal Medicine, West China Hospital of Sichuan University, Chengdu 610041, China.

出版信息

Int J Mol Sci. 2013 May 28;14(6):11392-401. doi: 10.3390/ijms140611392.

DOI:10.3390/ijms140611392
PMID:23759989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3709738/
Abstract

The -173 G/C polymorphism in the macrophage migration inhibitory factor (MIF) gene has been implicated in susceptibility to inflammatory bowel disease (IBD), but the results are inconclusive. The present meta-analysis aimed to investigate the overall association between the -173 G/C polymorphism and IBD risk. We searched in Pubmed, and Embase for studies evaluating the association between the -173G/C gene polymorphism and IBD risk. Data were extracted and statistical analysis was performed using Revman 5.1 and STATA 12.0 software. A total of seven publications involving 4729 subjects (2282 IBD cases and 2447 controls) were included in this meta-analysis. Combined analysis revealed a clear association between this polymorphism and IBD susceptibility (OR = 1.48, 95% CI: 1.10-2.00, p = 0.009 for CC vs. CG + GG). Subgroup analysis by ethnicity showed that the IBD risk associated with the -173G/C gene polymorphism was significantly elevated among Asians (OR = 1.79, 95% CI: 1.08-2.96, p = 0.02), but not among Caucasians. Subgroup analysis by disease suggested that the -173G/C gene polymorphism is a risk factor for ulcerative colitis (OR = 1.62, 95% CI: 1.10-2.37, p = 0.01), but that it was not associated with Crohn's disease. This meta-analysis suggests that the -173 G/C polymorphism in the macrophage MIF gene contributes to IBD susceptibility, specifically in Asian populations. Further studies are needed to validate these findings.

摘要

巨噬细胞移动抑制因子(MIF)基因 -173G/C 多态性与炎症性肠病(IBD)易感性有关,但结果尚无定论。本荟萃分析旨在研究 -173G/C 多态性与 IBD 风险之间的总体关联。我们在 Pubmed 和 Embase 中检索评估 -173G/C 基因多态性与 IBD 风险关联的研究。使用 Revman 5.1 和 STATA 12.0 软件提取数据并进行统计分析。本荟萃分析共纳入 7 篇文献,涉及 4729 名受试者(2282 例 IBD 病例和 2447 名对照)。合并分析显示该多态性与 IBD 易感性之间存在明显关联(CC 与 CG + GG 相比,OR = 1.48,95%CI:1.10 - 2.00,p = 0.009)。按种族进行的亚组分析表明,-173G/C 基因多态性相关的 IBD 风险在亚洲人中显著升高(OR = 1.79,95%CI:1.08 - 2.96,p = 0.02),而在白种人中未升高。按疾病进行的亚组分析表明,-173G/C 基因多态性是溃疡性结肠炎的危险因素(OR = 1.62,95%CI:1.10 - 2.37,p = 0.01),但与克罗恩病无关。本荟萃分析表明,巨噬细胞 MIF 基因的 -173G/C 多态性与 IBD 易感性有关,特别是在亚洲人群中。需要进一步研究来验证这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/3709738/8204cb162f1b/ijms-14-11392f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/3709738/b2ea671cc7ae/ijms-14-11392f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/3709738/04838519f95b/ijms-14-11392f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/3709738/8204cb162f1b/ijms-14-11392f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/3709738/b2ea671cc7ae/ijms-14-11392f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/3709738/04838519f95b/ijms-14-11392f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eb0/3709738/8204cb162f1b/ijms-14-11392f3.jpg

相似文献

1
The -173 G/C polymorphism of the MIF gene and inflammatory bowel disease risk: a meta-analysis.巨噬细胞移动抑制因子(MIF)基因-173 G/C多态性与炎症性肠病风险:一项荟萃分析
Int J Mol Sci. 2013 May 28;14(6):11392-401. doi: 10.3390/ijms140611392.
2
Association of the macrophage migration inhibitory factor gene--173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects.巨噬细胞移动抑制因子基因-173G/C 多态性与炎症性肠病的关联:4296 例患者的荟萃分析。
Gene. 2013 Sep 10;526(2):228-31. doi: 10.1016/j.gene.2013.05.012. Epub 2013 May 23.
3
Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.巨噬细胞移动抑制因子基因多态性与炎症性肠病的关联研究:新西兰白种人病例对照研究和荟萃分析。
World J Gastroenterol. 2013 Oct 21;19(39):6656-64. doi: 10.3748/wjg.v19.i39.6656.
4
Macrophage migration inhibitory factor -173G/C gene polymorphism increases the risk of renal disease: a meta-analysis.巨噬细胞移动抑制因子-173G/C基因多态性增加肾病风险:一项荟萃分析。
Nephrology (Carlton). 2015 Feb;20(2):68-76. doi: 10.1111/nep.12353.
5
Meta-analysis of macrophage migration inhibitory factor (MIF) gene -173G/C polymorphism and inflammatory bowel disease (IBD) risk.巨噬细胞移动抑制因子(MIF)基因-173G/C多态性与炎症性肠病(IBD)风险的Meta分析。
Int J Clin Exp Med. 2015 Jun 15;8(6):9570-4. eCollection 2015.
6
Contribution of Macrophage Migration Inhibitory Factor -173G/C Gene Polymorphism to the Risk of Cancer in Chinese Population.巨噬细胞移动抑制因子-173G/C基因多态性对中国人群癌症风险的影响
Asian Pac J Cancer Prev. 2015;16(11):4597-601. doi: 10.7314/apjcp.2015.16.11.4597.
7
Impact of Macrophage Migration Inhibitory Factor Gene Polymorphisms and Serum Macrophage Migration Inhibitory Factor Levels on Pulmonary and Spinal Tuberculosis Susceptibility: A Pooled Analysis.巨噬细胞移动抑制因子基因多态性及其血清水平对肺及脊柱结核易感性的影响:荟萃分析。
Genet Test Mol Biomarkers. 2022 Sep;26(9):430-442. doi: 10.1089/gtmb.2022.0068.
8
The Role of MIF-173G/C Gene Polymorphism in the Susceptibility of Autoimmune Diseases.MIF-173G/C 基因多态性在自身免疫性疾病易感性中的作用。
Mediators Inflamm. 2020 Apr 28;2020:7825072. doi: 10.1155/2020/7825072. eCollection 2020.
9
MIF -173G/C (rs755622) polymorphism modulates coronary artery disease risk: evidence from a systematic meta-analysis.MIF-173G/C(rs755622)多态性调节冠心病风险:系统荟萃分析证据。
BMC Cardiovasc Disord. 2020 Jun 19;20(1):300. doi: 10.1186/s12872-020-01564-4.
10
[Association between severe preeclampsia and single nucleotide polymorphism of macrophage migration inhibitory factors -173G/C].重度子痫前期与巨噬细胞移动抑制因子-173G/C单核苷酸多态性的相关性
Zhonghua Fu Chan Ke Za Zhi. 2012 May;47(5):342-6.

引用本文的文献

1
Targeting macrophage migration inhibitory factor as a potential therapeutic strategy in colorectal cancer.靶向巨噬细胞移动抑制因子作为结直肠癌的一种潜在治疗策略。
Oncogenesis. 2025 Aug 20;14(1):30. doi: 10.1038/s41389-025-00572-3.
2
Deep Insight into the Role of MIF in Spondyloarthritis.深入了解巨噬细胞移动抑制因子在脊柱关节炎中的作用。
Curr Rheumatol Rep. 2022 Sep;24(9):269-278. doi: 10.1007/s11926-022-01081-7. Epub 2022 Jul 9.
3
Influence of MIF polymorphisms on CpG island hyper-methylation of CDKN2A in the patients with ulcerative colitis.

本文引用的文献

1
Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectives.炎症性肠病的遗传学:西方与东方观点的比较。
J Gastroenterol Hepatol. 2013 Feb;28(2):220-6. doi: 10.1111/jgh.12053.
2
The economic burden of inflammatory bowel disease: clear problem, unclear solution.炎症性肠病的经济负担:问题明确,解决方案不明。
Dig Dis Sci. 2012 Dec;57(12):3042-4. doi: 10.1007/s10620-012-2417-8.
3
Molecular function of macrophage migration inhibitory factor and a novel therapy for inflammatory bowel disease.巨噬细胞移动抑制因子的分子功能与炎症性肠病的新型治疗方法。
巨噬细胞移动抑制因子基因多态性对溃疡性结肠炎患者CDKN2A基因启动子区CpG岛高甲基化的影响
BMC Med Genet. 2020 Oct 12;21(1):201. doi: 10.1186/s12881-020-01140-9.
4
The Role of MIF-173G/C Gene Polymorphism in the Susceptibility of Autoimmune Diseases.MIF-173G/C 基因多态性在自身免疫性疾病易感性中的作用。
Mediators Inflamm. 2020 Apr 28;2020:7825072. doi: 10.1155/2020/7825072. eCollection 2020.
5
Association between a Polymorphism and Susceptibility to Schizophrenia.**多态性与精神分裂症易感性之间的关联**。
Biomed Res Int. 2020 Mar 20;2020:1216303. doi: 10.1155/2020/1216303. eCollection 2020.
6
Macrophage Migration Inhibitory Factor -173 G/C Polymorphism: A Global Meta-Analysis across the Disease Spectrum.巨噬细胞移动抑制因子-173 G/C多态性:跨疾病谱的全球荟萃分析
Front Genet. 2018 Mar 1;9:55. doi: 10.3389/fgene.2018.00055. eCollection 2018.
7
MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus.巨噬细胞移动抑制因子:在系统性红斑狼疮病理病因学中的意义
Front Immunol. 2015 Nov 11;6:577. doi: 10.3389/fimmu.2015.00577. eCollection 2015.
8
The polymorphism (Gln261Arg) of 12-lipoxygenase and cancer risk: a meta-analysis.12-脂氧合酶的多态性(Gln261Arg)与癌症风险:一项荟萃分析。
Int J Clin Exp Med. 2015 Jan 15;8(1):488-95. eCollection 2015.
9
Contribution of NKX2-3 polymorphisms to inflammatory bowel diseases: a meta-analysis of 35358 subjects.NKX2 - 3基因多态性对炎症性肠病的贡献:对35358名受试者的荟萃分析
Sci Rep. 2014 Jan 29;4:3924. doi: 10.1038/srep03924.
10
The -159C/T polymorphism in the CD14 gene and cancer risk: a meta-analysis.CD14 基因-159C/T 多态性与癌症风险的关联:荟萃分析。
Onco Targets Ther. 2013 Dec 10;7:5-12. doi: 10.2147/OTT.S54547. eCollection 2013.
Ann N Y Acad Sci. 2012 Oct;1271(1):53-7. doi: 10.1111/j.1749-6632.2012.06735.x.
4
Crucial steps in the natural history of inflammatory bowel disease.炎症性肠病自然史中的关键步骤。
World J Gastroenterol. 2012 Aug 7;18(29):3790-9. doi: 10.3748/wjg.v18.i29.3790.
5
Single-nucleotide polymorphisms in inflammatory bowel disease.炎症性肠病的单核苷酸多态性。
Transl Res. 2012 Jul;160(1):45-64. doi: 10.1016/j.trsl.2011.10.006. Epub 2011 Nov 23.
6
Role of genetics in the diagnosis and prognosis of Crohn's disease.遗传学在克罗恩病的诊断和预后中的作用。
World J Gastroenterol. 2012 Jan 14;18(2):105-18. doi: 10.3748/wjg.v18.i2.105.
7
Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis.溃疡性结肠炎患者中巨噬细胞移动抑制因子、Toll 样受体 4 和 CD14 多态性及其表达水平改变。
Hum Immunol. 2012 Feb;73(2):201-5. doi: 10.1016/j.humimm.2011.12.006. Epub 2011 Dec 8.
8
Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.巨噬细胞移动抑制因子基因-173 G/C多态性对炎症性肠病风险的影响
Pol Przegl Chir. 2011 Feb;83(2):76-80. doi: 10.2478/v10035-011-0012-x.
9
Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis.亚洲炎症性肠病的遗传学:系统评价和荟萃分析。
Inflamm Bowel Dis. 2012 Jun;18(6):1164-76. doi: 10.1002/ibd.21845. Epub 2011 Sep 1.
10
Epidemiology and natural history of inflammatory bowel diseases.炎症性肠病的流行病学和自然史。
Gastroenterology. 2011 May;140(6):1785-94. doi: 10.1053/j.gastro.2011.01.055.